More than 50,000 patients from over a dozen nations have benefitted from the drug, developed by scientists at the Genetic and Biotechnology Engineering Center, Havana jointly with the Institute of Angiology and Vascular Surgery. (photo: Vicente Brito Santos/Escambray)

Escambray

9 March, 2012 - 9:13am